Abstract
TPDMT-4 is a pregnancy-dependent mouse mammary tumor line characterized by progressive growth in pregnant, but dormancy in virgin, hosts and by significant estrogen (ER) and progesterone receptor (PR) levels. Three sublines, T4-OR26, T4-0I96, and T4-0I320, were established from sporadic outgrowths in virgins of TPDMT-4 pieces passaged long in breeding and estradiol (E2)- plus progesterone-treated mice and of enzymatically dissociated TPDMT-4 cells, respectively. T4-OR26 tumors produced ovarian-responsive growth and maintained the parent levels of ER and E2-dependent PR. T4-OI320 and T4-OI96 tumors were ovarian independent or autonomous. The former had ER, but not E2-dependent PR, and the latter had neither. To clarify the mechanism of acquisition of autonomy by hormone-dependent neoplastic cells, comparative ER studies were conducted between TPDMT-4 and T4-OI320 tumors. Although cytosolic, microsomal, and nuclear translocated ER levels were generally lower in T4-OI320 tumors, the dissociation constants, determined by the dextran-charcoal technique, steroid specificity, sedimentation data in sucrose gradients, and activation studies using DNA binding, molecular transformation from 4S to 5S, and [3H]E2 dissociation from [3H] E2-ER complexes as markers, revealed no autonomy-specific changes in cytosolic ER. Small but significant differences in the affinity of [3H]E2 to nuclear ER and the [3H]E2 dissociation rate from nuclear bound [3H]E2-ER complexes were found between both tumors. Hormone-dependent tumors may progress toward autonomy with different receptor statuses in different environments, and lack of E2-dependent PR synthesis in ER-positive tumors may be due to defects at postreceptor or nuclear levels involving subtle changes in interaction between activated ER and nuclei.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have